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Summary 
Allelic exclusion at the T  cell receptor et locus  TCR-ot is incomplete, as demonstrated by the 
presence of a number of T  lymphocyte clones carrying two expressed ot chain products. Such 
dual 0t chain T  cells have been proposed to play a role in autoimmunity, for example, because 
of a second TCR-~x[3 pair having bypassed negative selection by virtue of low expression. We 
examined this hypothesis by generating mice of various autoimmunity-prone strains carrying a 
hemizygous targeted disruption of the TCR-cx locus, therefore unable to produce dual cx chain 
T  cells.  Normal mice have a low but significant proportion ofT cells expressing two cell-sur- 
face TCR-ot chains that could be enumerated by comparison to TCR-ot hemizygotes, which 
have none. Susceptibility to various autoimmune diseases was analyzed in TCR-ot hemizygotes 
that had been backcrossed to disease-prone strains for several generations. The incidence of ex- 
perimental allergic  encephalomyelitis and of lupus is not affected by the absence of dual TCR-ot 
cells.  In contrast,  nonobese  diabetic  (NOD)  TCRot  hemizygotes are  significantly protected 
from cyclophosphamide-accelerated insulitis and diabetes. Thus, dual ot T  cells may play an im- 
portant role in some but not all autoimmune diseases.  Furthermore, since protected and sus- 
ceptible NOD  mice both show strong spontaneous responses to glutamic acid decarboxylase, 
responses to this antigen, if necessary for diabetetogenesis, are not sufficient. 
I 
t is evident from analysis ofT cell clones and TCR trans- 
genic  mice  that  allelic  exclusion  is  incomplete for the 
TCR-o~ locus, as many T  cells are found to carry two func- 
tionally rearranged products (1-3). Using human peripheral 
blood,  it was estimated from the frequency of cells giving 
dual  staining  for  two  different  Vet  chain  antibodies  that 
~30% of human peripheral T  cells may express two func- 
tional TCR-ot chains  (4).  Such findings may have impor- 
tant implications for autoimmune disease:  any dual TCR-o~ 
T  cell may be positively selected using one TCR-ot[3 pair, 
but may prove autoreactive via its second o~ combination, 
particularly if escape is  facilitated by the  second  receptor 
being expressed at low density on emergent cells  (5).  For 
example, in  TCR  transgenic  mice  expressing an  anti-H- 
2K  b receptor, cells  expressing only the clonotypic cxl3 pair 
showed high TCR expression, while cells expressing two cx 
chains paired with the transgenic [3 chain had a lower TCR 
density.  On  crossing TCR  transgenic  mice with  a  trans- 
genic  line  expressing the  target  antigen,  only the  TCR  hi 
cells were deleted (5). 
We have explored the potential role of dual TCR-0~ T 
cells in autoimmune disease by backcrossing mice of several 
autoimmunity-prone strains onto a strain carrying a TCIL-e~ 
gene  disrupted  by  homologous  recombination  (6).  Mice 
homozygous for this mutation lack o~3 TCR-bearing cells, 
but  in  the  hemizygous  state,  they  appear  phenotypically 
and functionally normal (6,  7),  including the number and 
proportion ofCD3 + cells in the thymus and periphery (E1- 
liott, J.,  unpublished  observations). To assess the  effect of 
the hemizygous TCR-o~ mutation (and consequent inabil- 
ity to generate dual ot T  cells)  on type I  diabetes,  experi- 
mental  allergic  encephalitis  (EAE) 1,  and lupus,  the  muta- 
tion was bred for six or more generations onto each of the 
strains:  nonobese diabetic (NOD), SJL, and MRL lpr/lpr. 
Materials and Methods 
Mice.  A targeted mutation of the TCR-~x locus in 129 strain 
mice  (6)  was  crossed  for several  generations  onto  NOD,  SJL 
(CRC,  Harrow,  London,  UK),  and  MRL/lpr  (Olac,  Bicester, 
UK)  backgrounds.  Mice  carrying  the  targeted  disruption  were 
identified  by PCR  (8). Mice  crossed  to  the  NOD,  SJL, and 
MRL/Ipr strains were  analyzed  for disease incidence  at  six to 
seven backcross generations.  Wild-type controls  in each experi- 
ment are the  negative littermates  from mating of TCR-~ hem- 
izygotes. 
Genotypic Analysis.  In the case of TCR-~x hemizygous  mice 
crossed onto the NOD background,  genotypic analysis was con- 
ducted to analyze the relative contributions  of NOD and 129 se- 
quences, particularly in regions near to proposed diabetes suscep- 
tibility loci. The rmcrosatellite markers used were those described 
previously  (9-11).  Additional  markers  were obtained from the 
1Abbreviations used in this paper: EAE, experimental allergic encephalitis; 
GAD, glutamic acid decarboxylase; NOD, nonobese diabetic; PLP, pro- 
teolipoprotein. 
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markers were Adh-1, D3NdsS, D4Mit71 (Iddl I), D4Mit13, Zp-3, 
Ly-3,  Ckmm  (1dd7), Gfap  (Idd4), Igh,  D12Nds7,  D14Mittt 
(Idd12),  TCP,,-o~,  Nfl,  H-2  (lddl),  D1Mit5  (Idd5), D4Nds16 
(ldd9), D14Mitl, Qb-1, Ap2, D6Nds6, and Acrb. 
Flow  Cytometry.  I0  ~'  mesenteric  lymph  node  cells  were 
stained  at  4~  with  FITC-conjugated anti-Ve~8  (PharMingen, 
San Diego, CA) and PE-conjugated anti-Ve~8 (PharMingen). and 
analyzed on a  FACScan|  (Becton Dickinson &  Co.,  Mountain 
View, CA). A gate was defined such that the difference between 
the  Vot2+8 +  population  in  wild-type  mice  and  fluorescence 
background, as indicated by analysis of TCFZ-c~ hemizygote mice, 
was  maximized.  At  least  100,000  cells  were  acquired  for  each 
sample. 
Disease Induction and Analysis.  To induce EAE, mice received 
200 Ixg of proteolipoprotein (PLP) 139-15I peptide emulsified in 
IFA supplemented with 60 ~g mycobacteria (Mycobacterium tuber- 
adosis and Mycobacterium butyricum 8:1) subcutaneously on days 0 
and 7  (12).  Immediately after injection of antigen and 24 h later, 
mice received 200 ng of Bordetella pertussis toxin (Porton Products 
Ltd., Salisbury, UK) in PBS intraperitoneally. Mice were checked 
for signs of disease  from day 11:0 =  normal; I  =  limp tail; 2  = 
impaired righting reflex; 3 =  partial hindlimb paralysis;  4 =  com- 
plete hindlimb paralysis;  5 =  moribund. 
To  accelerate  diabetes  in  mice  on  the  NOD  background, 
TCR-~x  +/+  and TCR-o~ +/- mice were injected intraperitoneally 
with  200  mg/kg  cyclophosphamide  (Asta  Medica,  Cambridge, 
UK) (a drug that, while increasing the rapidity and incidence of 
diabetes in the NOD mouse, does not induce insulitis or diabetes 
in nomlal mouse strains  [13,  14],  NOD.H-2/' mice  [15],  or  F1 
crosses  of NOD with nomaal mice [14])  twice within a 14-d in- 
terval. 28 d  after the first  injection, the mice were killed. Blood 
glucose was measured at the time of death using Glucostix (Bayer 
Diagnostics, Basing'stoke, UK). Mice were 6-6.5 mo old at time 
of death. They were housed in a non-specific pathogen-free fa- 
cility, which retarded spontaneous disease  by "-'3 mo compared 
with incidence in our specific pathogen-free unit. Hematoxylin 
and eosin-stained pancreas sections were scored blind for islet pa- 
thology: I  =  peri-islet infiltration; 2 =  mild intra-islet infiltration; 
3  =  severe intra-islet infiltration; 4  =  loss  of islet architecture. 
Normal blood glucose was defined as being less than the mean + 
2.5  SI) of readings from  age-matched  NOD  mice  carrying an 
H-2Eot transgene, which confers complete protection from dia- 
betic pathology (16). 
To  assess susceptibility to  lupus,  sixth  generation  backcross 
MRL  lpr/lpr TCt<o~ +/+  and TClLci +7-  mice  were  immunized 
intradermally with 0.1  ml CFA to accelerate disease  (17).  Day 28 
serum samples were tested for c~-dsDNA antibodies in an ELISA 
using $1 nuclease-treated calf thymus DNA (Sigma lmmunochem- 
icals, St.  Louis, MO) -coated plates, essentially as described else- 
where (18). Mice were tested for hematuria on day 28, killed, and 
their blood was tested for uremia. Samples were assessed for he- 
maturia using Labstix  (Bayer Diagnostics) and for  uremia using 
Azostix (Bayer Diagnostics). 
T Cell Proliferation Assays.  Splenocytes from untreated NOD 
TCR.o~+/+  or TCP,.ci +/  12-wk-old mice were cultured in HL1 
medium  supplemented  with  antibiotics,  glutamine,  and  2-ME 
(Hycor Biomedical Inc.,  trvine, CA)  at  4  ￿  l0  s cells per well 
with 25  txg/ml recombinant rat  GAD67  protein (encompassing 
amino acids 332-584)  expressed  in the  pGEX1  vector or with 
control pGEX fusion protein (gifts from Dr. O. Birk, Weizmann 
Institute, R.ehovot, Israel).  As an additional control for any mito- 
genie or nonspecific effect of the antigen preparations, responses 
were  compared  between female mice and male littermates that 
were only mildly susceptible to disease.  Assays were  cultured for 
72 h, pulsed with l  I.tCi [3H]thymidine per well for the final 6 h 
and harvested for liquid scintillation counting. 
Results 
Frequency of Dual TCR-oe Cells.  We compared TCR-Ix 
hemizygote  (lacking dual o~  T  cells)  and  wild-type  litter- 
mates  for  the  presence  of T  cells  carrying both  Vcl2  and 
Vix8  (Fig.  1).  To calculate the frequency of dual cx T  cells 
in wild-type mice  (Table  1),  the  number of lymphocytes 
found in the double-positive FACS|  gate above the back- 
ground  staining from  equivalently gated  TCRot +/-  litter- 
mate cells was derived. The frequency of such lymphocytes 
suggests that ~  of mature T  cells express two  cell-sur- 
face  ~  chains.  This  estimated percentage  of dual ot  cells is 
derived  from  the  observed  frequency of Vot2 +  and V(x8 + 
A  B 
! 
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Figure  1.  Identification  of 
cells expressing two  Vex chains. 
(A) Wild-type or (/3) hemizygote 
littermates  were  compared  for 
staining ofa Vcx2+8  + population. 
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Number per 100,000 T  cells 
{x2+8 +  Estimated Percentage 
Number of events  (Background  of cells bearing two 
Vix2 +  V0e8 +  in double-positive gate  subtracted)  TCR-ot chains 
NOD TCR-cr +/  7,700  _+ 270  2,600  _  100  10.8  _+ 3.7  0  3.700 
NOD TCR.-ot +/+  8,300  __ 390  2,700  -4-  130  35.0  +_ 9.9  24.2  10.8 
The frequency  ofT cells for Vcl2 +, Vcl8 +, or V{x2+8  + is indicated.  The mean number of cells within the gated region for TCR-{x  +/- mice (, = 
5) was 10.8, and this was subtracted  from the gated cell count of wild-type littermates  01 =  5). Parallel staining  of samples with FITC-conju- 
gated {x-CD3 was used to calculate the number ofT cells in each test. 
*See text for derivation of the percentage of dual TCR-o~ T cells. 
cells.  Thus,  if  all  cells  carried  two  cell-surface  TCR-ot 
chains,  the proportion  ofVot2 + cells carrying V{x8 +  would 
be 0.027  X  0.083,  i.e., 224:100,000.  Since a  mean of 24.2 
Va2+8 + cells were found, the frequency of dual {x T  cells is 
24.2/224  =  10.8%. 
Incidence of Diabetes  and  Insulitis  in  TCR-oe  Hemizygous 
NOD  Mice.  TCR-{x  hemizygous  of~pring  were  com- 
pared  with  wild-type  littetmates  for  incidence  of cyclo- 
phosphamide-induced  diabetes. Both female and male NOD 
TCR-{x +/-  mice were  significantly protected  from induc- 
tion  of diabetes  assessed  by  islet  infiltration  (Fig.  2)  and 
blood  glucose  (Fig.  3).  Only  two  male  and  one  female 
TCR-{x +/-  mice  showed  moderate  islet  infiltration  and 
none  displayed  elevated blood  glucose levels.  Since it was 
possible  that  by backcrossing  the  homologous  recombina- 
tion  event from chromosome  14  of the founder  129  mice 
onto NOD  we may have selected against an NOD  diabetes 
susceptibility  locus,  we  conducted  a  PCR  analysis  with 
markers linked to the known  NOD  susceptibility loci (Ta- 
ble  2).  The  strongest  susceptibility  locus,  which  is  within 
the H-2  region,  is entirely NOD-derived  in  the nfice that 
were analyzed. Furthermore, Iddl I (D4Mit71),  ldd7 (Cknml), 
and  Idd4  (Grip)  (19)  are  entirely  of NOD  origin  in  these 
mice. The microsatellites that have previously been used  to 
define  Idd5  and  ldd9  were  not  informative  in  this  strain 
combination.  17 of 18 NOD  TCR-{i +/-  mice described in 
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Figure  2,  Incidence  of insulitis in  NOD TCR-~x +/+ and TCR-ix+/ 
mice.  Disease compared  in (A) sixth generation  female and  (B) seventh 
generation  male, NOD backcross, TCR-{x +/+, and TCR-ct+,- mice. 
1 .........  7  8 ....................  20 
TCR  (z +/-  TCR  c~  +/+ 
Figure  3.  Incidence  of diabetes in NOD TCR-cr  and TCP.-cl+/- 
mice.  Disease was compared  in (A) sixth generation  ibmale, and (/3) sev- 
enth  generation  male,  NOD  backcross,  TCR-o~ ~/+,  and  TCP.-ci4/- 
mice. 
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Genomes in Test Mice with Respect to Microsatellite Markers Linked 
to Known Diabetes Susceptibility Lod 
No. mice 
No. mice  with one copy 
with two  of the 129 allele 
Chromosome  copies of the  (no. displaying 
(location, cM)  Locus  NOD allele  histopathology) 
3 (83)  Adh-1  44 (20)  0 
3 (86)  D3Nds5  44 (20)  0 
4 (55)  D4Mit71  44 (20)  0 
4 (65)  D4Mit13  44 (20)  0 
5 (73)  Zp-3  44 (20)  0 
6 (32)  Ly-3  19 (11)  25  (9) 
7 (4)  Ckmm  44 (20)  0 
11  (59)  Gfap  44 (20)  0 
12 (65)  Igh  44 (20)  0 
12 (66)  D12Nds7  44 (20)  0 
14 (2)  D14Mitll  25 (16)  19 (4) 
14 (18)  TCR-~x  26 (17)  18 (3) 
14 (27)  Nfl  27  (17)  17 (3) 
17 (19)*  H-2  44 (20)  0 
17 (19)  Qb-1  44 (20)  0 
For analysis of the NOD v  129 contribution to TCR-ot  +/- (n =  18) 
and TCR-ct  +/+ (n =  26) mice in the sixth and seventh backcross gen- 
eration, PCR was used to distinguish between NOD and 129 microsat- 
ellites and H-2-specific markers* that were specific for H-2A  b. 
this paper carry one copy of the 129 Nfl allele, located ~-'20 
centimorgans from the TCR-ot locus. Among the insulin- 
dependent  diabetes  mellitus  disease  markers  previously 
mapped in a NOD  backcross, the NOD  alleles at two loci 
near the Plau locus on chromosome 14 conferred moderate 
protection (Idd8) in a  C57BL/10  backcross (9),  or moder- 
ate  susceptibility (Idd12)  in  SJL  and  C57BL/6  backcrosses 
(10). While any cosegregating 129 gene would need to ex- 
ert a very strong protective effect over and above any of the 
NOD  allele, this remains a theoretical possibility, and some 
caution  should  be  exercised in  interpreting  the  results  as 
being caused by the absence of dual TCR-ot T  cells until it 
becomes possible to repeat such  studies using homologous 
recombination to disrupt TCR-t~ in NOD  embryonic stern 
cells. While it is possible that  the  129  contribution  could 
decrease  the  overall  diabetes  rate,  only  chromosome  14 
genes cosegregating with the mutant TCR-ot could poten- 
tially  contribute  to  the  relative  disease  susceptibility be- 
tween  TCR-ot  hernizygous  and  wild-type  mice  at  any 
given  generation.  While  the  fact  that  three  TCR-ot+/- 
mice developed moderate insulitis indicates that protection 
which may be afforded by the absence of dual c~ T  cells is 
incomplete, the results suggest that these cells may play an 
important role in diabetes pathogenesis. 
T  Cell Responses to Glutamic Acid Decarboxylase (GAD) in 
Protected TCR-e~ Hemizygous  NOD Mice.  Recent  studies 
have investigated the islet autoantigens recognized by NOD 
T  cells (20, 21); while the primary target is still unclear, GAD 
is a strong candidate. We compared the spontaneous T  cell 
response  to  GAD  67  of NOD  mice with  or without  dual 
TCR-ct  T  cells  (Fig.  4),  confirming that  NOD  mice  re- 
spond spontaneously to  GAD.  However,  strong responses 
were found in both groups of mice, despite the fact that the 
vast majority of TCR-~ +/-  mice do not develop islet pa- 
thology. The  T  cell response to  control fusion protein in 
each case was in the range of 10-15% of the response to re- 
combinant  GAD  protein:  the  mean  response  to  control 
pGEX protein the experiment shown was 1,486  +  967. As 
a further control for nonspecific or mitogenic effects of the 
GAD fusion protein, we analyzed the response to recombi- 
nant  GAD in male NOD  mice,  which  are less susceptible 
to  disease and  make  reduced  responses  to  a  range  of islet 
antigens, including GAD. We  conclude that if T  cell rec- 
ognition of GAD is necessary for development of disease, it 
is not sufficient. 
Incidence of EAE in Hemizygous Mutant Mice.  TCR-c~ +/- 
mice crossed onto an SJL background and wild-type litter- 
mates were compared for susceptibility to EAE induced by 
immunization with the dominant encephalitogenic epitope 
for this strain, PLP  139-151  (13).  No difference was found 
between the two groups (Fig. 5). 
Incidence  of  Lupus  in  Hemizygous  Mutant  MRL  lpr/Ipr 
Mice.  Female backcrossed TCR-00/-mice  developed sim- 
ilar levels  of ot-dsDNA  antibodies  and  kidney  disease  to 
wild-type littermates (Fig. 6). All mice were affected, mean 
peak antibodies being 0.77  +  29  in TCR-ot +/-  mice  (ab- 
sorbance at  1/50  dilution) and 0.82  +  0.32  in TCR-eO/+ 
Figure 4.  Both protected (TCR-a  +/-) and suscepti- 
ble (TCR-e~+/+) NOD mice respond spontaneously to 
GAD. The T cell response of splenocytes from (A) fe- 
male NOD mice and (B) male NOD mice in response 
to GAD is shown, with TCR-ct+/- mice in each case 
to the left of the vertical bar and TCR-~x+/+ mice to 
the right. Black bars show the mean [3H]thymidine  in- 
corporation (+SE) in triplicate cultures from individual 
mice. 
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Figure  5.  Both  TCR-(x+/+  and  TCR-oe+/-  mice  are  susceptible to 
EAE. Induction of EAE in SJL TCR-cl+/+  (closed circles, n  =  11) and SJL 
TCR-~x+/-  mice  (open  circles,  n  =  5).  PLP  139-151-immunized  mice 
were scored blind for clinical symptoms. The  figure shows a  typical ex- 
periment: all mice in both groups were affected on day 14. The range of 
disease scores at this time point was 3.5--4.5 in hemizygous mice and 4-4.5 
in wild-type littermates. 
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Figure  6.  Both TCR-c~+/+ and TCR-ct+/-  mice are susceptible to lu- 
pus.  c~-dsDNA antibodies were measured in female MRL  lpr/lpr TCR- 
e~+/-  (n  =  7),  TCR-c~+/+  httermates  (n  =  8)  and  C57BL/10  control 
mice  (n  =  6).  ct-dsDNA  antibody  ELISA  readings:  TCR-ot+/-  (open 
squares),  TCR-~ +/+  (closed  triangles),  C57BL/10  (open  circles),  no  serum 
(dotted  line).  No  macroscopic  evidence  of arthritis  was  found  in  any 
mouse. 
mice.  No  significant  difference  between  antibody  titers  of 
TCR-ot +/-  and TCR-(x +/+  mice was found  at any point. 
Analysis of hematuria  and  uremia  also revealed no  signifi- 
cant difference between groups (data not shown). 
Discussion 
The  finding  that a  substantial  proportion  of human  pe- 
ripheral  blood  T  cells  possess  two  cell  surface  TCR-~x 
chains  and  consequently  two  distinct  TCR-o~[3  pairs  has 
important  implications  for autoimmunity  (4).  It has  been 
suggested  that  T  cells  positively selected  through  one  (x13 
pair may prove autoreactive via another. We examined this 
hypothesis by derivation of mice from strains susceptible to 
autoimrnune  diseases and that are hemizygous for an engi- 
neered  mutation  in  the  TCR-ot  locus.  Because  a  direct 
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comparison can be made between FACS|  staining of dual 
ot  chain  cells  in  normal  mice  and  hemizygotes,  the  true 
number  of cells  of this  type  can  be  assessed  more  confi- 
dently than is possible in human peripheral blood, where a 
figure for the proportion of dual TCR-0~ T  cells approach- 
ing 30% was derived. A  caveat to the estimate in humans is 
that  FACS|  noise  (i.e.,  events  falling  within  the  dual  a 
chain-positive  gate as a  result  of nonspecific  staining with 
antibody)  may have added to the  apparent frequency.  The 
use  of TCR-ot  hemizygous  mice  as  a  background  from 
which  to  calculate  FACS|  noise  has  allowed  us  to  show 
that in mice, only ~10%  of peripheral  T  cells possess two 
cell-surface TCR-ix chains at detectable  levels, as extrapo- 
lated from the proportion ofV{x2+er  + cells. 
NOD  TCR-{x hemizygous mice were substantially pro- 
tected from the induction  of insulitis  and diabetes.  Impor- 
tantly, such protection is not complete, as evidenced by is- 
let infiltration in three mice in this study, as well as by the 
occasional occurrence of overt diabetes in TCR-ix hemizy- 
gous  mice  during  the  course  of backcrossing  the  TCR-oe 
mutation  (consequently outside of any controlled compari- 
son with  wild-type  littermates).  Protection  in hemizygous 
mice may theoretically be the consequence  of immunolog- 
ical changes  and/or  genetic  changes  at a  NOD  disease lo- 
cus.  According  to  the  immunological  explanation,  which 
we  consider  the  more  likely,  the  dual  TCR-{x  T  cells 
would  have  some  significant  role  in  diabetogenesis.  It  is 
implicit in the hypothesis that the dual TCR-(x T  cell pop- 
ulation is likely to harbor a disproportionately high number 
of autoreactive  cells.  Any  hypothesis  for  the  role  of dual 
TCR-(x  cells in  autoreactivity  must  explain  why  dual  re- 
ceptors  are  not  subject  to  negative  selection  at  the  same 
stringency  as single  receptors.  This  may result  if a  second 
receptor  were  expressed  at  low  density.  While  our  data 
suggest that dual TCR-(x T  cells have a role in the patho- 
genesis of diabetes, it is clear that pathogenic T  cells, either 
in  this  disease  or in  other  autoimmune  diseases,  need  not 
necessarily be of this type. Thus, in EAE and diabetes TCR 
transgenic models, the incidence  of spontaneous disease ac- 
tually  increases  when  TCR  transgenic  mice  are  crossed 
onto  a  "knockout"  background  precluding  the  expression 
of endogenous ot chains  (22).  Furthermore,  a number of T 
cell  clones  that have been  shown  to  transfer autoimmune 
disease only express a single TCR-e~[3 pair (23). 
A  more  trivial  explanation  of  protection  in  TCR--{x 
hemizygote NOD  would be that it is dependent  on a dia- 
betes gene linked to the TCR-ix locus on chromosome  14 
of the  129 strain. Since the study used wild-type littermates 
of TCR-{x hemizygote mice as the control for diabetes in- 
cidence,  the  two groups differ significantly only at loci on 
chromosome  14,  and  hence  it  is  highly  unlikely  that  the 
disease susceptibility difference between  the two is depen- 
dent on diabetes loci on other chromosomes.  It is possible, 
however,  that  contamination  with  unidentified  regions  of 
the  129 genome lowered  the  overall diabetes incidence  in 
both groups. 
The  generation  of NOD  mice  that  are  resistant  to  the 
development of diabetes enabled us to ask how protection correlated with the presence or absence of T  cell responses 
to candidate islet autoantigens.  A  number  of groups dem- 
onstrated that  insulin-dependent diabetes mellitus patients 
analyzed  early in  disease  make  T  cell  responses  to  GAD 
(24-26).  The  response  to  the  two  isoforms,  GAD  65  and 
GAD 67,  are among the earliest antiislet responses detect- 
able in NOD  mice, and tolerogenic immunization with ei- 
ther isofoml can reduce or delay the onset of disease (20, 
21, 27). We analyzed responses to GAD 67 since this is the 
predominant  GAD isoform expressed in  NOD  islets (28). 
Wild-type NOD  mice,  which  are susceptible to  diabetes, 
or  their  TCR-c~  hemizygous  littermates,  which  are  not, 
make  identical responses to  the  GAD  67  fragment  tested. 
This suggests that if the T  cell response to GAD is indeed 
necessary for pathogenesis, as implied by the tolerance in- 
duction experiments, it is not sufficient. One caveat is that 
the  fragment  we  used  encompasses  only amino  acid resi- 
dues,  332-584;  it  therefore  contains  most  of  the  key 
epitopes that have previously described in patients or NOD 
mice (e.g., the 509-528 and 524-543  epitopes described by 
Kaufinan et al. (20),  the 550-585  fragment in Elliott et al. 
(27), and a major disease-associated epitope in patients (26). 
The fragment, however, lacks the 247-266  epitope recog- 
nized in some diabetes studies (20, 25). 
To  conclude our report,  the  data we present show first 
that  dual ci T  cells are present in mice at a low frequency 
(,'~10%). Second, while dual 0~ T  cells are not a prerequisite 
for autoimmune  disease per se,  they may strongly predis- 
pose to the induction of NOD  diabetes. 
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